Adverum Biotechnologies Inc ADVM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
14.14UNCH (UNCH)
Volume
108,994
52 week range
6.81 - 29.70
Loading...
  • Open14.63
  • Day High14.81
  • Day Low13.83
  • Prev Close14.66
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low6.81
  • 52 Week Low Date04/10/23

Key Stats

  • Market Cap293.475M
  • Shares Out20.75M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change87.83

KEY STATS

  • Open14.63
  • Day High14.81
  • Day Low13.83
  • Prev Close14.66
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low6.81
  • 52 Week Low Date04/10/23
  • Market Cap293.475M
  • Shares Out20.75M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • YTD % Change87.83

RATIOS/PROFITABILITY

  • EPS (TTM)-11.62
  • P/E (TTM)-1.22
  • Fwd P/E (NTM)-1.90
  • EBITDA (TTM)-118.147M
  • ROE (TTM)-88.43%
  • Revenue (TTM)3.60M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,254.58%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adverum Biotechnologies Inc

 

Profile

MORE
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response...
Patrick Machado J.D.
Independent Chairman of the Board
Laurent Fischer M.D.
President, Chief Executive Officer, Director
Kishor Soparkar J.D.
Chief Operating Officer
Linda Rubinstein
Chief Financial Officer
Andrew Ramelmeier Ph.D.
Chief Technology Officer
John Rakow
General Counsel
Address
100 Cardinal Way
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
PGEN
Precigen Inc
1.45UNCHUNCH
INZY
Inozyme Pharma Inc
7.66UNCHUNCH
THRD
Third Harmonic Bio Inc
9.44UNCHUNCH
HUMA
Humacyte Inc
3.11UNCHUNCH
AVIR
Atea Pharmaceuticals Inc
4.04UNCHUNCH